S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.75 (+0.83%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.75 (+0.83%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.75 (+0.83%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.75 (+0.83%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
Log in
NASDAQ:PTGX

Protagonist Therapeutics SEC Filings & 10K Form

$23.97
+0.84 (+3.63 %)
(As of 11/27/2020 12:01 PM ET)
Add
Compare
Today's Range
$23.20
Now: $23.97
$24.93
50-Day Range
$18.49
MA: $21.01
$23.13
52-Week Range
$4.47
Now: $23.97
$24.02
Volume7,852 shs
Average Volume494,489 shs
Market Capitalization$917.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54

SEC Filings

Protagonist Therapeutics (NASDAQ:PTGX) SEC Filings

DateFilerForm TypeView
11/04/2020
4:21 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
4:12 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
4:13 PM
Protagonist Therapeutics (Filer)
Form 8-K/A
09/11/2020
3:32 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
4:33 PM
O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
3:34 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2020
4:38 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:07 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
5:21 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:19 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:18 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:16 PM
Noonberg Sarah B. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:15 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
5:12 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
8:47 PM
Protagonist Therapeutics (Filer)
Form 424B5
05/11/2020
6:00 AM
Protagonist Therapeutics (Filer)
Form 424B5
05/07/2020
3:34 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2020
4:32 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2020
4:29 PM
Protagonist Therapeutics (Filer)
Form DEFA14A
04/16/2020
4:28 PM
Protagonist Therapeutics (Filer)
Form DEF 14A
04/08/2020
4:46 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
5:14 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:42 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
12:04 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
6:26 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
4:24 PM
Protagonist Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/10/2020
4:17 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2020
4:49 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:48 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:46 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:45 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:44 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
3:05 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
5:19 AM
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
12/16/2019
10:06 AM
Protagonist Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
12/03/2019
5:46 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:32 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:11 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:10 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
6:50 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2019
4:12 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2019
3:53 PM
Protagonist Therapeutics (Filer)
Form 424B5
11/27/2019
1:58 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2019
11:15 PM
Protagonist Therapeutics (Filer)
Form EFFECT
11/06/2019
4:11 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:33 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
4:25 PM
Protagonist Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/31/2019
3:51 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
5:17 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
5:15 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:21 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
8:29 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:49 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
06/17/2019
3:05 PM
Protagonist Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
06/13/2019
3:02 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
5:33 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:31 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:29 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:28 PM
Noonberg Sarah B. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:26 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:20 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:40 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:35 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2019
3:49 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
5:43 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:32 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
6:08 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
6:04 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:27 PM
Protagonist Therapeutics (Filer)
Form DEFA14A
04/26/2019
4:25 PM
Protagonist Therapeutics (Filer)
Form DEF 14A
04/02/2019
6:19 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
6:16 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
3:01 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
7:52 PM
Protagonist Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2019
3:26 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:06 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
5:35 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:33 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:32 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:29 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:27 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:18 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/13/2019
12:44 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/08/2019
4:37 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:30 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:27 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
12:09 PM
CANAAN X L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/16/2019
5:42 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
7:29 PM
Murphy Niall (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2019
6:00 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
5:08 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/31/2018
3:20 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
7:30 AM
PERCEPTIVE ADVISORS LLC (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
11/27/2018
3:29 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:57 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:28 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:37 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
4:26 PM
Protagonist Therapeutics (Filer)
Form 424B3
09/23/2018
11:16 PM
Protagonist Therapeutics (Filer)
Form EFFECT
09/06/2018
8:43 PM
Protagonist Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.